CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
amiodarone amiodarone +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000531
NCT00000531Phase 3Completed
CompareCT.gov

Antiarrhythmics Versus Implantable Defibrillators (AVID)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 14, 2016

In Brief

A Phase 3 clinical trial evaluating defibrillators, implantable, amiodarone amiodarone, and 1 other intervention for Arrhythmia and 5 related conditions. Completed.

Detailed Summary

To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated from sudden cardiac death who are otherwise at very high risk of mortality from arrhythmic causes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiovascular Diseases, Death, Sudden, Cardiac, Heart Diseases, Tachycardia, Ventricular, Ventricular Fibrillation
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1992
Study CompletionAug 1, 2002
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

defibrillators, implantabledevice

amiodarone amiodaronedrug

sotaloldrug